Brentuximab vedotin plus bendamustine is an effective salvage regimen for pediatric patients with relapsed Hodgkin lymphoma Meeting Abstract


Authors: Gulati, N.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jackson, C.; Kernan, N.; Kung, A. L.; O'Reilly, R.; Prockop, S.; Ramaswamy, K.; Scaradavou, A.; Spitzer, B.; Shukla, N.; Steinherz, P. G.; Forlenza, C.
Abstract Title: Brentuximab vedotin plus bendamustine is an effective salvage regimen for pediatric patients with relapsed Hodgkin lymphoma
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419705349
PROVIDER: wos
Notes: Meeting Abstract: 5172 -- Source: Wos
MSK Authors
  1. Nancy Kernan
    380 Kernan
  2. Farid Boulad
    254 Boulad
  3. Susan E Prockop
    161 Prockop
  4. Kevin Joseph Curran
    58 Curran
  5. Peter G Steinherz
    169 Steinherz
  6. Richard O'Reilly
    487 O'Reilly
  7. Neerav Shukla
    72 Shukla
  8. Barbara Spitzer
    28 Spitzer
  9. Maria   Cancio
    4 Cancio
  10. Andrew L Kung
    24 Kung
  11. Nitya Gulati
    3 Gulati